betapharm Arzneimittel GmbH v. Amgen Inc.: Discovery Application

Application by betapharm Arzneimittel GmbH, of Germany, to take discovery from Amgen Inc., of Delaware, “for use in German patent infringement actions and opposition proceedings before the European Patent Office”, filed at the U. S. District Court for the Central District of California.

  • 146
    May 06, 2021
    Amgen Inc.
    Foley & Lardner, Kimberly Dodd
    Xx Xx Xx
    betapharm Arzneimittel GmbH